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Abstract: Current understanding of fibrosis remains incomplete despite the increasing burden of
related diseases. Preclinical models are used to dissect the pathogenesis and dynamics of fibrosis,
and to evaluate anti-fibrotic therapies. These studies require objective and accurate measurements
of fibrosis. Existing histological quantification methods are operator-dependent, organ-specific,
and/or need advanced equipment. Therefore, we developed a robust, minimally operator-dependent,
and tissue-transposable digital method for fibrosis quantification. The proposed method involves a
novel algorithm for more specific and more sensitive detection of collagen fibers stained by picrosirius
red (PSR), a computer-assisted segmentation of histological structures, and a new automated
morphological classification of fibers according to their compactness. The new algorithm proved
more accurate than classical filtering using principal color component (red-green-blue; RGB) for PSR
detection. We applied this new method on established mouse models of liver, lung, and kidney fibrosis
and demonstrated its validity by evidencing topological collagen accumulation in relevant histological
compartments. Our data also showed an overall accumulation of compact fibers concomitant
with worsening fibrosis and evidenced topological changes in fiber compactness proper to each
model. In conclusion, we describe here a robust digital method for fibrosis analysis allowing
accurate quantification, pattern recognition, and multi-organ comparisons useful to understand
fibrosis dynamics.
Keywords: fibrosis; picrosirius red; digital analysis; collagen proportionate area; whole section;
region-of-interest; fibrosis pattern
1. Introduction
Fibrosis is a pathological manifestation of excessive or inappropriate wound healing resulting in
collagen deposition that may affect the function of diverse organs [1]. So far, no effective anti-fibrotic
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therapy is available while the burden of fibrotic diseases is increasing and intense research on preclinical
models is underway. Therefore, accurate and reliable quantification of collagen deposits and their
characterization are necessary to stage and map the natural history of diseases, to study the pathogenesis
of fibrosis, to identify therapeutic targets, to evaluate anti-fibrotic strategies or to validate non-invasive
diagnostic tools.
Collagen biochemical assays (e.g., hydroxyproline measurements) on total tissue homogenate
provide a global estimation of collagen levels within a tissue specimen. However, this approach faces
multiples limitations: (1) techniques are somehow painstaking (hydroxyproline content or sodium
dodecyl sulfate-polyacrylamide gel electrophoresis followed by densitometry analysis) or require
purification steps to limit overestimation (Sircol) [2], carrying the risk of missing a significant
component in discarded fractions; (2) they include both induced and structural collagen; (3) histological
compartments cannot be distinguished, complicating data interpretation and hiding subtle changes [3].
Alternatively, histopathological parameters based on collagen staining on tissue sections have
been validated in many organs and disease conditions for the grading and the staging of fibrosis or for
follow-up purposes. In this approach, the first critical step is to provide a specific signal. The most
common techniques to visualize collagen deposits are the Masson’s trichrome and picrosirius red
(PSR) (Sirius red F3B, Direct red 80). Both dyes possess good affinity for collagen fibers owe to multiple
base-acid interactions, with PSR having a higher binding affinity for fibrillary collagen because of its
elongated chemical structure, as confirmed by immunodetection [4–6]. PSR staining offers numerous
advantages: besides being inexpensive, PSR solution is stable for years, the staining protocol is fast and
simple, consistent in terms of sensitivity and hue [5], and provides a contrasted staining that enables a
more reliable evaluation of fibrosis than with the Masson’s trichrome [7–9]. Several protocols have
been described for PSR staining, the most common being with yellow counterstaining by picric acid
only which provides a good signal-to-noise ratio [4,10], with the use of additional dyes for specific
applications [11,12] or combined with immunohistochemistry but with some limitations [13].
The staining interpretation represents the second critical step. It requires (1) the accurate and
reliable detection of the signal over noise, (2) the identification of the relevant histological structures,
and (3) a meaningful quantification. This can be achieved by skilled pathologists or using digital
image analysis (DIA), both methods having intrinsic strengths and limitations. On the one hand,
trained human brains can perform incredibly fast for completing scoring systems (i.e., Ishak, Metavir,
or Ashcroft systems), but these human resources are usually limited and inter- and even intra-individual
variations are a well-known source of error [14,15]. Furthermore, these scoring systems are by essence
descriptive or only semi-quantitative, and comprehensive information from whole tissue PSR-stained
sections remains under-exploited. On the other hand, modern DIA has benefited of the onset of
artificial intelligence. Advanced algorithms have been developed to recognize some specific fibrosis
patterns [16–18], but these methods require software that can be expensive and proper training.
Furthermore, they are not intended for multi-organ comparison since their transposition would require
specific adaptation and optimization. This can be solved by computer-assisted recognition of tissue
architecture followed by automated quantification of fibrosis on large tissue samples [19–22], thereby
outclassing visual scoring on selected fields of view.
Outcomes generated by DIA can then be expressed as the area occupied by collagen out of
the entire examined tissue section (referred to as collagen proportionate area, CPA). This accessible
method is in use for fibrosis quantification in the liver [8,23–27], kidney [9,28,29], or lung [26,30].
Additionally, DIA combined with advanced microscopy (second harmonic generation) allows the
morphometric segmentation of collagen fibers and hence discriminating aggregated and distributed
fibers [31,32]. Nevertheless, to the best of our knowledge, no transposable method to quantify fibrosis
in multiple organs and to characterize fibrosis dynamics on PSR-stained sections imaged in brightfield
has been reported.
The present DIA method was developed to offer (1) a robust and versatile quantification that
enables the regionalized analysis of fibrosis in diverse tissues for multi-organ or inter-study comparison
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and (2) objective parameters to characterize the pattern of collagen deposits by the comprehensive
analysis on large tissue specimens.
2. Materials and Methods
2.1. Murine Models of Fibrosis
We used in the present study recognized models of liver, kidney or lung fibrosis. All male mice
were kept under standard laboratory conditions in 12:12 h light-dark cycles, and food and water were
supplied ad libitum. Animal procedures were in accordance with the National Research Council Guide
for the Care and Use of Laboratory Animals, in agreement with ARRIVE guidelines 2.0, and were
approved by the Institutional Review Board of UCLouvain (liver model: 2012/UCL/MD/026; lung
model: 2018/UCL/MD/012; kidney model: 2018/UCL/MD/015). In every model, control animals were
compared with animals exposed to the fibrosis agent and sacrificed at two time points corresponding
to intermediate and severe fibrosis. We analyzed n = 5 animals for each group and time point.
2.1.1. Liver Fibrosis
Carbon tetrachloride (CCl4)-induced liver fibrosis is a classical and robust model of bridging
fibrosis in rodent. CCl4 is specifically metabolized in ~50% of hepatocytes in the center of the liver lobule
to induce an acute CYP2E1-dependent production of highly reactive tricholoromethyl free radicals,
causing centro-lobular necrosis that triggers a wound healing response. When the insult is repeated,
successive rounds of wound healing occur, causing peri-central fibrosis and progressively forming
fibrotic bridges between vascular structures dissecting the parenchyma [33,34]. Fifteen 7-week-old
C57BL/6J male mice were purchased from Janvier (Le-Genest-St-Ile, France). Ten mice received an
intraperitoneal injection of CCl4 (800 µL/kg body weight in corn oil) three times a week to induce
fibrosis. Among them, five mice were treated for 2 weeks to induce incomplete central bridges (named
hereafter 2w CCl4 group) and five mice were injected for 7 weeks to yield severe bridging fibrosis
(7w CCl4 group) [33,34]. The remaining five mice received the vehicle only (controls). At the time of
sacrifice, 48 h after the last injection, mice where anesthetized. The caudate and the left lateral liver
lobes were dissected out, fixed with 4% formaldehyde for 24 h and embedded in paraffin.
2.1.2. Lung Fibrosis
Pulmonary fibrosis is a well-known side effect of bleomycin treatment because the lung expresses
extremely low levels of bleomycin hydrolase. In the presence of iron and oxygen, non-hydrolyzed
bleomycin generates reactive oxygen species. Subsequent cytotoxic lipid peroxides and oxidized
proteins cause tissue injury and parenchymal fibrosis [35]. Fifteen 8-week-old C57BL/6J female mice
were purchased from Janvier (Le-Genest-St-Ile, France) and divided in three groups of five animals.
In the first group, the mice received a single endotracheal instillation with 0.02 IU bleomycin in 50 µL
saline and were sacrificed 28 days after instillation. The unique instillation of bleomycin (named
after BLM-acute) is a model known to induce a rapid but transient fibrosis. In the second group,
the mice underwent repeated endotracheal instillation with 0.02 IU once-a-week for 8 weeks to
promote severe and persistent fibrosis [35,36] (BLM-chronic). The control group was instilled with
saline solution only. At the time of sacrifice, mice were anesthetized by an intraperitoneal injection of
20 mg sodium pentobarbital (Certa, Braine-l’Alleud, Belgium). One lung was dissected out, fixed with
4% formaldehyde for 24 h and embedded in paraffin.
2.1.3. Kidney Fibrosis
Kidney fibrosis is a primary dose-limiting side effect of antineoplastic treatment with cisplatin.
Cisplatin is predominantly eliminated by the kidney, accumulating in the cells lining the proximal
and more distal tubules. Intracellular accumulation of cisplatin generates reactive oxygen species,
cytotoxicity, and DNA damage, causing a cortical fibrosis sparing the glomeruli [37]. Kidney fibrosis was
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generated using a well-established model of repeated low-dose cisplatin, as previously described [38].
Fifteen male FVB/n mice aged 8–10 weeks (Charles River, Brussels, Belgium) were administered a
weekly intraperitoneal injection of low-dose cisplatin (7 mg/kg, Sigma-Aldrich, Overijse, Belgium) for
3 or 4 weeks (named after 3w CIS and 4w CIS groups) vs. normal saline only (controls). At the time of
sacrifice, mice where anesthetized, one kidney was dissected out, fixed with 4% formaldehyde for 24 h
and embedded in paraffin.
2.2. Tissue Preparation and Standardized Protocol for Picrosirius Red Staining
Protocol for PSR staining was performed as described [4,5] with recent optimization [10]. Briefly,
5 µm paraffin sections [20] were first deparaffinized and rehydrated. Slides were immersed in 1.0%
phosphomolybdic acid solution for 2 min for pH acclimatization and yellow counterstaining [10],
rinsed in water and then incubated in a saturated aqueous picric acid solution containing 0.1% Direct
red 80 (Sigma #365548) for 2 h at room temperature. After a brief 2 min wash in 0.01 N HCL and an
additional wash in water, slides were dehydrated and mounted with a Dako automated coverslipper.
Tissue sections were digitalized using a SCN400 slide scanner (Leica Biosystems, Wetzlar, Germany) at
20×magnification.
2.3. Analysis Workflow
Whole tissue sections were analyzed using the image analysis tool Author™ version 2017.2
(Visiopharm, Hørsholm, Denmark) in order to (1) detect the tissue and assist the definition of
histological compartments, (2) detect PSR staining, and (3) quantify this staining. These three steps are
described hereafter.
2.3.1. Tissue Recognition and Computer-Assisted Segmentation of Histological Compartments
In all models, the tissue section was automatically defined. Artifacts and regions-of-exclusion
(ROEs, listed in Table 1) were then automatically discarded and manual correction applied when
required (i.e., incomplete or incorrect automatic detection). Total tissue area was quantified. Then,
computer-assisted delineation of regions-of-interest (ROIs) was performed for each tissue model.
Details and illustrations are provided in Supplementary Material 1. Briefly,
1. For liver sections, connective tissue was classified as perivascular ROI when it directly surrounded a
lumen (with or without erythrocytes) or as bridges when located in the parenchyma. The remaining
tissue was considered as parenchyma.
2. For the lung, large connective tissue surrounding air ducts was discarded since its presence was
highly variable between sections, introducing a bias. PSR staining was referred as peri-air ducts
or perivascular ROIs when found at a maximum distance of 25 µm from air ducts (bronchi and
bronchioles) or from blood vessels. The remaining tissue was considered as parenchyma.
3. For the kidney, the inner medulla, the outer medulla, and the cortex were manually defined based
on morphological criteria, as described [39]. The cortex was further separated divided into large
cortical vessels and vessel-free cortex.
ROIs and ROEs are illustrated in Figure 1. The respective proportion of the area of each ROI vs.
total tissue area was calculated as
Relative ROI area =
Σ Area selected ROI
Area total tissue
× 100 (in %) (1)
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Figure 1. Illustration of fibrosis development in the murine models of liver (A–C), lung (D–F) and
kidney (G–I) fibrosis. Representative samples of control (A), 2w CCl4 (B), and 7w CCl4 (C) livers;
control (D), BLM-acute (E), and BLM-chronic (F) lungs; control (G), 3w CIS (H), and 4w CIS (I) kidneys.
Global view of entire histological sections (scale bar = 1 mm) and higher magnification of specific
regions (inserts).
2.3.2. Optimized Algorithm to Detect PSR-Stained Collagen Deposits and Fiber Segmentation
Two detection methods for PSR staining were designed and illustrated in the Supplement
Material 2. The first method (PSRRGB) extracted the red pixels of red-green-blue (RGB) filtering
(RGB-G filter). For the second method optimized for increased selectivity and specificity (PSROPT),
images were preprocessed using a combination of RGB-G and H-AEC filters to generate an image of
the noise filter. This noise was subtracted to red–green contrast filter providing a robust detection of
the true signal. Chromaticity red filter completed this detection thanks to its high resolution. Based on
this optimized detection, PSR-stained collagen fragments were subsequently segmented (PSRMORF)
by watershed and object separation and then classified according to their intensity values and density
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into strongly stained and plain segments (compact fibers) or weakly stained and loose segments
(scattered fibers), in a close manner as defined elsewhere [31]. For each detection method, one threshold
was arbitrarily chosen on stained vs. non-stained regions of the three organs to allow multi-organ
comparison, as explained in Supplementary Material 3.
2.3.3. PSR-Stained Collagen Deposits Quantification Parameters
Collagen proportionate area (CPA) value is a morphometric measurement of signal density. Values
were calculated as conventionally defined [9,23–26,28–30]. When performed on the entire tissue
section, the measure was here referred to as in toto CPA [Equation (2)]. When tissue is segmented
in multiple ROIs, additional information becomes available such as the distribution of all collagen
among the different ROIs, defined here as collagen proportion [CP, Equation (3)], and the proportion of
collagen detected in a specific ROI within total tissue, defined here as ROI CPA [Equation (4)]. These
measurements were calculated as follows:
In toto CPA =
stained area total tissue
area total tissue
× 100 (in %) (2)
Collagen proportion =
Σ stained area selected ROI
stained area total tissue
× 100 (in %) (3)
ROI CPA =
Σ stained area selected ROI
area total tissue
× 100 (in %) (4)
The same parameters were applied for the quantification of compact and scattered fibers detected
with the PSRMORF method. Quantifications were performed at maximal resolution and raw values
were expressed as µm2.
The analysis workflow is illustrated in Figure 2.
(
𝑰𝒏 𝒕𝒐𝒕𝒐 𝐂𝐏𝐀 =  𝒔𝒕𝒂𝒊𝒏𝒆𝒅 𝒂𝒓𝒆𝒂 𝒕𝒐𝒕𝒂𝒍 𝒕𝒊𝒔𝒔𝒖𝒆𝐚𝒓𝒆𝒂 𝒕𝒐𝒕𝒂𝒍 𝒕𝒊𝒔𝒔𝒖𝒆   ×  𝟏𝟎𝟎 (𝒊𝒏 %)
𝐂𝐨𝐥𝐥𝐚𝐠𝐞𝐧 𝐩𝐫𝐨𝐩𝐨𝐫𝐭𝐢𝐨𝐧 =  𝚺 𝒔𝒕𝒂𝒊𝒏𝒆𝒅 𝒂𝒓𝒆𝒂 𝒔𝒆𝒍𝒆𝒄𝒕𝒆𝒅 𝑹𝑶𝑰𝒔𝒕𝒂𝒊𝒏𝒆𝒅 𝐚𝒓𝒆𝒂 𝒕𝒐𝒕𝒂𝒍 𝒕𝒊𝒔𝒔𝒖𝒆   ×  𝟏𝟎𝟎 (𝒊𝒏 %) 
𝐑𝐎𝐈 𝐂𝐏𝐀 =  𝚺 𝒔𝒕𝒂𝒊𝒏𝒆𝒅 𝒂𝒓𝒆𝒂 𝒔𝒆𝒍𝒆𝒄𝒕𝒆𝒅 𝑹𝑶𝑰𝐚𝒓𝒆𝒂 𝒕𝒐𝒕𝒂𝒍 𝒕𝒊𝒔𝒔𝒖𝒆   ×  𝟏𝟎𝟎 (𝒊𝒏 %)  
μ
Figure 2. Analysis workflow for in toto vs. regionalized quantification using the three developed
detection algorithms: RGB method (PSRRGB), optimized method (PSROPT) or morphological fiber
classification (PSRMORF). ROI, region-of-interest; ROE, region-of-exclusion; CPA, collagen proportionate
area; CP, collagen proportion.
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2.4. Statistics
Statistical analyses were performed using GraphPad Prism 8 on Windows10. One-way ANOVA
were performed with Fisher’s post-hoc test. For correlation analysis, coefficient of determination
(goodness-of-fit, R2) was computed with a confidence interval of 95%. For the fiber classification,
inter-group comparisons were achieved by one-way ANOVA, while intra-group comparisons were
computed by paired (CP) or unpaired (ROI CPA) T-tests. The respective control group for each model
served for the multiple comparisons. p-value < 0.05 was considered significant. Values are reported as
the mean ± standard deviation (SD).
3. Results
3.1. Visual Examination of the Histological Sections
As expected, specimen examination revealed that CCl4 exposure causes a peri-centrilobular liver
fibrosis characterized by thickening of the vascular wall and progressive development of centro-central
bridges in a time-dependent manner (Figure 3A). In the lungs, instillation of bleomycin induced
alveolar hyperplasia (more extensive in the chronic model), patchy alveolar fibrosis, and inflammatory
and/or fibroblastic foci often localized close to blood vessels (Figure 3B). Cisplatin injections led to the
development of a time-dependent fibrosis around proximal and distal tubules in the inner layer of the
renal cortex, as well as in the inner and outer medulla (Figure 3C).
 
Figure 3. Computer-assisted segmentation of histological structures in the three studied organs.
An illustration is given before (left) and after (right) semi-automated segmentation in (A) a 7w
CCl4 liver, (B) a BLM-chronic lung, and (C) a 4w CIS kidney. Details in Supplementary Material 1.
Scale bar = 1 mm.
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3.2. A Robust and Tissue-Transposable Algorithm to Detect PSR Staining in Diverse Fibrotic Organs
The first objective of the present study was to robustly detect PSR staining with an algorithm
applicable to diverse organs. In first intention, we applied an RGB-based filtering to uncover PSR-stained
pixels. As shown in Figure 4B, there is an apparent lack of sensitivity as fibers were incompletely
detected (blue arrows). Moreover, despite a low detection threshold, non-PSR stained pixels were
recognized as staining (Figure 4B, black arrow). These errors were more frequent in the livers than in
lungs or kidneys.
To improve the specificity and sensitivity of the detection, we developed an optimized algorithm
based on a more robust filtering of stained pixels (PSROPT method). This preprocessing increased the
specificity for PSR staining vs. background, allowing lower detection threshold and more dynamic
range, thereby also improving sensitivity of the detection (Figure 4C and Supplementary Material 2D).
 
μ
Figure 4. Detection methods of discrete liver fibrosis stained in PSR. (A) Native image. (B) PSRRGB
detection method, using RGB-G filter (insert f1). Staining detection is highlighted in red. Blue arrows:
undetected pixels (false negative); black arrow: unsaturated pixels (false positive). (C) PSROPT
detection method using optimized filters (inserts f2 and f3). Staining detection is highlighted in red.
(D) Optimized detection is used for morphological segmentation (based on fiber density and staining
intensity) with algorithm PSRMORF. Compact fibers are labeled in red and scattered fibers are labeled
in blue. Refer to Supplementary Materials 2 and 3A for the filters, the detailed procedure, and the
dynamic ranges of sensitivity. Scale bar = 50 µm.
The specificity and sensitivity of PSRRGB and PSROPT detection methods were assessed by
comparing in toto CPA values between organs at baseline and between the different time points within
the same model. In accordance with the visual appraisal of staining at baseline (see Figure 3), in toto
PSROPT CPA were ~4× higher in the control lungs than in the livers and the kidneys (Figure 5B and
Supplementary Material 3B), and this difference was lower with the PSRRGB method (Figure 5A).
Comparing in toto CPA in the treated groups vs. their respective controls, PSRRGB method evidenced
fibrosis only at the latest time point of treatment in livers and kidneys and with chronic bleomycin
treatment in the lungs (Figure 5A). By contrast, fibrosis at the early time point and progressive fibrosis
were evidenced in the three organs using PSROPT (Figure 5B).
Correlation between the two methods was modest with a correlation coefficient weaker for the liver
sections (0.499) as compared with the lungs (0.647) and the kidneys (0.693) (Supplementary Material 3C),
tentatively explained by a higher noise in the liver fibrosis model.
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These results suggest that the PSRRGB detection method is not sensitive enough to highlight
collagen deposits accumulation during fibrosis onset in these models, and this limitation could be
circumvented, at least partially, by the PSROPT method.
 
Figure 5. In toto CPA analyses using PSRRGB (A) vs. PSROPT (B) filtering method for signal detection.
Quantification performed on entire tissue sections (ROEs excluded). One-way ANOVA with Fisher’s
post-hoc test. a: p < 0.050, b: p < 0.010, c: p < 0.001 vs. controls; *: p < 0.050, $: p < 0.001 last time point
vs. intermediate time point.
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3.3. Regionalized Analysis Revealed Topical Fibrosis Changes
The second aim was to evaluate whether regionalized analysis would allow a better characterization
of fibrosis. To meet this goal, histologically relevant ROIs were defined for each organ (Figure 1 and
Supplementary Material 1). The list of ROIs and ROEs and the relative area of ROIs are given in Table 1.
PSR staining was then quantified in each ROIs using the PSROPT detection method. Results were
expressed as CP (distribution of collagen among different ROIs) and ROI CPA (percentage of collagen
detected in a specific ROI within total tissue).
Table 1. Characteristics of regions-of-interest (ROIs) and regions-of-exclusion (ROEs).
Total Tissue













Liver 43.3 (13.9) Perivascular tissue 1.20 (0.32) 1.92 (0.70) 0.007 Capsule
Bridges 0.04 (0.02) 2.79 (0.30) <0.001 Large lumens
Parenchyma 98.76 (0.30) 95.29 (0.84) <0.001
Lung 32.77 (6.18) Peri-air ducts tissue 4.22 (0.39) 4.24 (0.81) 0.950 Pleura




Parenchyma 92.85 (0.95) 92.83 (1.01) 0.973 Large lumens & arteries
Kidney 17.63 (1.73) Inner medulla 4.46 (1.15) 6.49 (3.07) 0.204 Capsule
Outer medulla 10.88 (2.32) 13.03 (2.61) 0.205 Hilum
Cortex 84.66 (1.78) 80.48 (2.81) 0.022 Large lumens
1 Last time point of treatment (liver: 7w CCl4; lung: BLM-chronic; kidney: 4w CIS).
2 Strongly stained fibers
surrounding very large air ducts were included in the total tissue area but not considered as a ROI. This region
represented 5.02% (1.42) and 6.46% (2.12) of the total tissue area (p > 0.05).
3.3.1. Liver Fibrosis
While in normal livers, parenchyma represented more than 95% of the tissue sections (Table 1),
PSR staining in this region only corresponded to ~10% of the total collagen amount (Table 2). The greatest
CP was detected in the perivascular areas. This proportion decreased proportionally as the bridges
formed (Table 2). Although the ROI CPA moderately increased around vascular structures in fibrotic
livers (~2 times), this increase was much larger and time-dependent in bridges (~70 times at 2 weeks
and ~130 times at 7 weeks). Collagen accumulation in the parenchyma and outside the fibrous septa
was only detectable in the severe fibrotic condition (Figure 6).
Table 2. Liver collagen proportion per ROI. Mean percentages (±SD).
Collagen Proportion (%) Controls 2w CCl4 p-Val 7w CCl4 p-Val
Perivascular 85.71 (11.10) 64.22 (7.71) 0.006 45.06 (11.40) <0.001
Bridges 1.89 (1.94) 32.09 (7.72) <0.001 46.27 (8.44) <0.001
Parenchyma 12.40 (9.24) 3.69 (1.24) 0.037 8.67 (4.04) 0.334
Total 100% 100% 100%
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Figure 6. Liver ROI CPA calculated for each ROI using the PSROPT detection method. Mean (±SD) and
one-way ANOVA with Fisher’s post-hoc test. a: p < 0.050, b: p < 0.010, c: k vs. controls; $: p < 0.001 vs.
middle group.
3.3.2. Lung Fibrosis
As shown in Table 1, the distribution of the ROIs (peri-air ducts, perivascular tissue,
and parenchyma) was similar in the normal and bleomycin-treated tissues. In the healthy lung,
the greatest CP was detected in the parenchyma (~75%), where it further increased after single
or repeated bleomycin instillation (Table 3). The ROI CPA around air ducts was unchanged after
fibrosis induction, but bleomycin caused a significant enrichment of PSR staining in the perivascular
region (Figure 7).
Table 3. Lung collagen proportion per ROI. Mean percentages (±SD).
Collagen Proportion (%) Controls BLM-Acute p-Val BLM-Chronic p-Val
Perivascular 5.46 (1.58) 4.89 (1.84) 0.556 5.10 (0.80) 0.709
Peri-air ducts 19.64 (5.45) 8.66 (2.61) 0.001 9.81 (1.43) <0.001
Parenchyma 74.91 (6.39) 86.44 (4.33) 0.002 85.09 (1.74) 0.004
Total 100% 100% 100%
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Figure 7. Lung ROI CPA calculated for each ROI using the PSROPT detection method. Mean (±SD) and
one-way ANOVA with Fisher’s post-hoc test. b: p < 0.010, c: p < 0.001 vs. controls.
3.3.3. Kidney Fibrosis
Under normal condition, the cortex was the dominant ROI (85% of the tissue) (Table 1) and the
most important source of PSR signal (~85%); a large part of it was attributed to vessels (Table 4).
Cisplatin treatment induced a reduction of the relative cortical area (Table 1), a time-dependent increase
in the CP in the cortex (not attributed to vessels) and an elevation of the CP within the outer medulla
(Table 4). The ROI CPA was increased in the inner medulla, outer medulla and cortex upon cisplatin
administration (Figure 8A), with the largest accumulation in the (vessel-free) cortex (Figure 8B).
The results of in toto CPA were validated independently, by using a previously described DIA method
for PSR analysis [40] (Supplementary Material 4).
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Table 4. Kidney collagen proportion per ROI. Mean percentages (±SD). Cortex was sub-analyzed to
distinguish the parenchyma (1) and the large cortical vessels (2).
Collagen Proportion (%) Controls 3w CIS p-Val 4w CIS p-Val
Inner medulla 10.29 (7.95) 15.83 (3.78) 0.147 14.54 (4.28) 0.257
Outer medulla 4.94 (1.07) 13.06 (3.49) <0.001 4.98 (1.62) 0.979
Cortex 1,2 84.78 (8.59) 71.10 (4.02) 0.004 80.48 (4.60) 0.286
Total 100% 100% 100%
1 Cortex (minus vessels) 36.07 (8.00) 54.90 (4.57) 0.001 65.33 (8.51) <0.001
2 Large cortical vessels 48.70 (10.52) 16.21 (7.87) <0.001 15.15 (6.46) <0.001
Figure 8. Kidney ROI CPA calculated using the PSROPT detection method for each ROI (A) and in
sub-analyzing the cortex (B). Mean (±SD) and one-way ANOVA with Fisher’s post-hoc test. b: p < 0.010,
c: p < 0.001 vs. controls; *: p < 0.050, #: p < 0.010, $: p < 0.001 last time point vs. intermediate time point.
3.4. Morphological Parameters for Fibrosis Classification
Our third aim was to provide a tool for the automated categorization of collagen deposits based on
the morphological organization of the fibers, as proposed. Using the same detection filter than PSROPT,
a new algorithm (PSRMORF) was developed to automatically segment the PSR fibers by watershed and
separate objects, and quantify collagen fibers defined as compact or scattered based on the mean signal
intensity of each segment (Figure 4D) (details given in Supplement Material 2B,D).
3.4.1. In Toto Analysis of Fiber Morphology
Because the fiber classification by PSRMORF was obtained from PSROPT algorithm, the sum of the
two types of fibers calculated in toto is equal to the values described above (Figure 5 bottom panels).
Compact fibers were dominant in control livers and kidneys, representing respectively ~75% and 60%
of total collagen (Figure 9A,C), while the normal lung was proportionally richer in scattered fibers,
(Figure 9B), at least after exclusion of the dense connective tissue surrounding air ducts as detailed
above. Fibrosis in the liver was characterized by a proportional increase in both compact and scattered
fibers. In contrast, bleomycin and cisplatin caused a preferential accumulation in scattered fibers in
lungs and kidneys.
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Figure 9. In toto analysis of compact and scattered fibers using PSRMORF detection method, performed
in total tissue for (A) the livers, (B) the lungs and (C) the kidneys. Mean (±SD) and one-way ANOVA
with Fisher’s post-hoc test. a: p < 0.050, b: p < 0.010, c: p < 0.001 vs. controls; #: p < 0.010, $: p < 0.001
last time point vs. intermediate time point.
3.4.2. Regionalized Analysis of Fiber Morphology
Spatiotemporal fibrotic changes were investigated by calculating the evolution of the relative
proportion of compact and scattered fibers in each ROI (Table 5) and of their abundance in the
tissue (Figure 10).
In livers, the compact fibers mostly located in the perivascular connective tissue and the bridges,
while scattered fibers were predominant in the parenchyma, irrespectively to the fibrotic status (Table 5).
The modest increase in collagen amount detected in the perivascular area of CCl4-treated livers was
attributed to a local enrichment in compact fibers (Figure 10A). The bridges showed gradual increase in
the abundance of both fiber types upon CCl4 treatment, with compact fibers being twice predominant
over the scattered fibers (Figure 10B). Collagen fibers that accumulated in the parenchyma after 7 weeks
of treatment displayed mostly a scattered phenotype (Figure 10C).
In normal lungs, all compartments comprised both compact and scattered fibers. Upon fibrosis
induction, higher proportion of scattered fibers was detected around the air ducts (both dosing regimen)
and the vessels (BLM-acute only) (Table 5). In the parenchyma, bleomycin did not change the fiber
proportion (two-thirds scattered, one-third compact) (Table 5), presumably because both fiber types
accumulated in this ROI (Figure 10F). The two regimens increased the abundance of scattered fibers
around vessels whereas a net increase in compact fibers was detected only in the chronic model
(Figure 10D). The area surrounding air ducts remained essentially unaffected (Figure 10E).
In normal kidneys, the inner and outer medullas were mostly made up of scattered fibers, while
the cortex was enriched in compact fibers. Cisplatin treatment did not change these proportions in
the medulla but reversed the balance in the cortex (Table 5). Looking at the regional abundance per
fiber type of fiber, cisplatin increased collagen deposits in all compartments, especially in the form of
scattered fibers. Compact fibers also accumulated in all ROIs of cisplatin-treated kidneys compared to
controls, particularly in the cortex in a time-dependent manner (Figure 10G–I), pointing to the cortex
as a primary site of dense interstitial fibrosis.
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Figure 10. Regionalized analysis of compact and scattered fibers with PSRMORF detection method.
Results are shown in the liver for the perivascular region (A), bridges (B), and parenchyma (C), in the
lung for the perivascular region (D), the peri-air duct region (E), and the parenchyma (F), and in the
kidney for the inner medulla (G), the outer medulla (H) and the cortex (vessels included) (I). Mean
(±SD). One-way ANOVA with Fisher’s post-hoc test. a: p < 0.050, b: p < 0.010, c: p < 0.001 vs. controls;
*: p < 0.050, #: p < 0.010, $: p < 0.001 last time point vs. intermediate time point.
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Table 5. Collagen proportion (%) per fiber type in specific histological compartments. Mean
percentages (±SD).
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4. Discussion
Whole slide imaging and modern DIA at high resolution enlarge the possibilities for accurate
quantification. In the present study, we exploited DIA to address the said limitations of analyzing
PSR stained sections. We studied three organs in which assessment of fibrosis is of clinical relevance.
For this, we developed algorithms to (1) focus the analysis on parenchymal compartments and exclude
physiologically collagen-rich structures and (2) quantitatively describe the morphological organization
of PSR-stained collagen fibers, here defined as compact or scattered.
4.1. Novelty, Advantages, and Limitations of the Proposed Method
In line with previous comparisons of red-component (RGB-G) vs. color-specific threshold for PSR
staining analysis [22], we found the RGB-based method relatively poorly sensitive, and particularly for
detecting early or faint fibrosis. The PSROPT algorithm was thus optimized to be more sensitive and
more specific to PSR staining, and minimally dependent on the thresholding. Similar to [20] on severe
cardiac fibrosis, our method exploited the red-green contrast filter for PSR detection. However, thanks
to the addition of other preprocess filters, the dynamic range of detection of PSROPT was not only
(i) more robust to naturally occurring intra- and inter-studies variations, but also (ii) ampler than that of
PSRRGB method (illustrated in the Supplementary Material 2). Indeed, the use of hue-saturation-value
(from which derives chromaticity filtering) can explain the gain in robustness to staining variations
and optimal detection of faint signal [41].
The analysis of the entire tissue (in toto results) is a fast, simple and reliable tool for global detection
of accumulated collagen. However, thanks to the regionalized quantifications, we can reveal additional
changes, unsuspected or hidden in the global analysis. We provide thereby a tool to (i) evaluate whether
fibrosis occurs in a regionalized manner or not, (ii) quantitatively document the relative distribution of
collagen according to the histological structure, and (iii) quantify local collagen accumulation in the
specific ROI(s). It is thus now possible to finely characterize fibrosis specificities in various organs
using the same methodology (as discussed below).
Finally, our method offers a morphometric analysis of the organization of collagen deposits.
Beside collagen content, automated fiber segmentation enables to distinguish small intertwined fibers
from large clumps, each collagen segment being classified according to the mean intensity value of all
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the pixels that compose it. Thus, the segmentation in ROIs and the classification in fiber types offer a
refined description of fibrosis for assessing spatiotemporal changes in a finely tuned manner [21].
Our method has some limitations:
(1) Intrinsically, the analysis of tissue section is an incomplete representation of the
three-dimensional structures.
(2) Despite the computer-assisted recognition of the structures, the validation of the ROIs remains
essential. This manual correction is a non-negligible source of error.
(3) The outcomes are defined by an arbitrary-defined threshold, based on visual evaluation.
The developed PSROPT algorithm limits the impact of adjusting threshold. Robustly standardized
histological procedures are still essential before quantitative DIA.
(4) The classification into compact and scattered fibers was not based on the collagen nature or
effective physical parameters but on the rationale estimation that denser or thicker collagen fibrils
contain more basic residues binding the dye and are therefore more intensively stained.
4.2. Biological Results
4.2.1. Liver Fibrosis
First, the progressive 2- and 3-fold accumulation of collagen deposits found after 2 weeks or
7 weeks exposure to CCl4 was in line with existing literature [42,43]. In accordance with previous
analyses in the same model [44,45], our regionalized analysis located most of the accumulated collagen
in the bridges. This local enrichment of collagen in the bridges could be attributed to both compact
(predominant) and scattered fibers. This agrees with earlier reports showing a relative increase in
aggregated fibers with extended exposure to CCl4 [44]. Bridges have been shown to be rich in type I,
III and IV collagen [42,45], with a prominent role of type III and IV during fibrosis progression [19,45].
Since PSR indifferently stains these three types of collagens [5,6,46], our results should reflect any
change in the sum of these different fibers. Besides bridges, we also evidenced larger amount of collagen
deposits in the parenchyma after long-term treatment (7 weeks), potentially corresponding to small or
early forming deposits. Usually not integrated in the pathological descriptors, this information obtained
by regionalized analysis however indicates a worsening of the disease. Together, our data confirm
the progressive local accumulation of collagen in the bridges in response to CCl4 in a time-dependent
manner, starting as scattered fibers and evolving to a more compact phenotype. Whether the distribution
of scattered vs. compact fibers in the bridges and parenchyma reflects the enrichment in one type of
collagen and/or reflects disease progression or resolution remains to be elucidated.
We can conclude that CCl4 hepatotoxicity is characterized by the accumulation of dense collagen
fibers around vessels, and a strong induction of the bridging fibrosis that progresses with exposure time.
4.2.2. Lung Fibrosis
Bleomycin, irrespectively of the instillation protocol, induced a significant increase in collagen.
The histological aspect of bleomycin-treated lungs fairly recapitulates the observations of the
fundamental study by Degryse and Lawson [36]. The authors noted patchy areas of parenchymal
fibrosis in the acute model, while the chronic model was characterized by coexistence of normal
lung, dense scar, active remodeling with interstitial collagen deposition, and alveolar hyperplasia.
In our specimens, we saw no dense scar, while we noted foci located close to vessels in a variable
proportion between samples. The regionalized analysis pointed to a predominant parenchymal fibrosis
in bleomycin-treated lungs, irrespective of the administration protocol but with a greater extend in
the repetitive model. This interstitial fibrosis was a mixture of compact and loose fibers, with an
increasing role of the compact fibers in the chronic model, suggesting a more severe status after repeated
instillation [47]. Lung fibrotic regions have been shown to be rich in type IV collagen [48], which does
not organize in dense beams of fibers, possibly explaining the predominance of scattered fibers in our
study. Our results also suggest a local effect in the direct vicinity of blood vessels. First, we noted an
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accumulation of fibro-inflammatory foci close to the vasculature. Second, the two-classes segmentation
of fibers showed a perivascular enrichment in scattered fibers in all treated lungs and an accumulation
of dense fibers in this region only in chronic-treated lungs. This suggests that fibrosis induced by
chronic exposure to bleomycin is more compact, perhaps more mature, and/or less subject to resorption
than after a unique instillation [36]. Our results may support the concept of vascular alterations in
the initiation of interstitial fibrosis and disease progression, as already proposed [49,50]. Interestingly,
the formation of vessel-related structures seen by medical tomography in fibrotic patients can predict
the likelihood of decline of the forced vital capacity [51] underlying the key role of vasculature in the
disease. Bleomycin-induced fibrosis causes bronchial dilation [52], a phenomenon also seen in patients.
In our study, while the collagen amount at the margin of air ducts remained unaffected in fibrotic
samples, an increase proportion of scattered fibers was noted in this ROI. It is possible that fibers are
mechanically stretched, and therefore appear less dense.
In conclusion, bleomycin induces a parenchymal lung fibrosis, and our data support a pathological
action on the vasculature.
4.2.3. Kidney Fibrosis
In patients, chronic use of cisplatin causes significant tubular atrophy and interstitial fibrosis
with relative glomerular sparing. The repeated low-dose model used here mimics this condition more
closely than the standard models (with unique and higher dose) in terms of effect on kidney function,
kidney damage (interstitial cortical fibrosis) and survival rate [38].
The samples used here recapitulated the 3-fold increase in collagen deposition after 4 weeks of
cisplatin as documented [38].
However, our sensitive method allowed to detect fibrosis as early as 3 weeks after the initiation of
the cisplatin treatment. At this time-point, collagen accumulated in the cortex, essentially in the form
of scattered fibers. One week later as fibrosis progressed, fibers were more compact, with no impact
on large cortical vessels. These observations support the current understanding of cortical uptake
and tubular alteration by cisplatin leading to fibrosis in these regions, despite vasculature injury [37].
Both the inner and outer medulla displayed collagen accumulation, in line with recent untargeted
metabolomics data showing higher sensitivity of the medulla to cisplatin than the cortex [53]. This
increase was characterized by a strong accumulation of scattered fibers, but also of compact fibers,
suggesting fibrosis maturation similarly to the cortex.
4.3. Perspectives for Digital Pathology and Research
We demonstrate here the relevance and reproducibility of analyzing the local collagen accumulation
in specific tissue compartments, a fortiori in the form of compact or scattered fibers with accessible
material (paraffin sections), using a standard method (PSR staining) and a standard imaging system
(brightfield slide scanner). Nevertheless, to go further in this characterization, complementary
techniques are needed.
First, as illustrated in this work, an unbiased definition of the structures of interest for the
different organs is needed, especially owing the possibility to fully automatize this key step by
artificial intelligence [17,54,55].
Second, PSR stained sections can then be visualized with brightfield microscope but also under
circular polarized light (although polarization data remain matter to debate for their interpretation) or
fluorescent illumination, the latest possibly being as sensitive as the second harmonic generation for
collagen detection [56–58]. Therefore, the validation of our morphometric classification of the compact
vs. scattered fibers may be addressed by one of these relatively accessible methods in the future.
Alternatively, label-free second-harmonic generation/two-photon excited fluorescence microscopy
may address this question. Indeed, when combined with deep learning, this is used to reveal the
spatiotemporal changes in liver fibrosis [27,31,32,44,59,60]. This technology is promising since the recent
marketing of a slide scanner using this microscopy method for clinical applications [61]. Furthermore,
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another type of advance microscopy (staining-free fluorescence lifetime imaging) is proposed to
distinguish type I vs. type III collagen [62], but this claim still needs validation by complementary
approaches such as immunohistology. With such technologies, additional morphometric features
can be investigated such as the fiber length, diameter, orientation, alignment, anisotropy, or shape
factors (i.e., waviness) which have been associated with pathologies, developing the concept of
pathology-associated collagen signatures [63,64]. Such classification could ultimately serve to stratify
the degree of fiber density and compactness using conventional microscopy.
5. Conclusions
The golden rules for a reliable method are simplicity (easy to handle, low manpower need, etc.) and
reproducibility within and between studies. Our new digital method to detect collagen fibers using PSR
staining in brightfield is simple, robust, efficient, and tissue-transposable, allowing inter-studies and
multi-organ comparison. The regionalized analysis offers a spatiotemporal characterization of collagen
deposit organization and the proposed method of fiber classification enables pattern recognition to
better describe fibrosis characteristics. Beside the useful place of PSR for accurate diagnosis, the present
work implicates that the analysis opportunities offered by this staining are often underexploited.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-273X/10/11/1585/s1.
Supplementary Material 1: Computer assisted organ-specific definition of the regions-of-interest. Supplementary
Material 2: Detection filters and threshold determination for the RGB-based or the PSR-optimized methods.
Supplementary Material 3: RGB-based and the PSR-optimized methods used for multi-organ comparison in
liver, lung, and kidney (illustration and correlation). Supplementary Material 4: Validation of the developed
PSR-optimized method vs. previously described PSR-detection method on murine kidney samples.
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